Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis

BACKGROUND: CD133 and Nestin, as the markers of cancer stem cells, have recently been reported frequently in the pathogenesis and development of human gliomas. However, the prognostic role of CD133 and Nestin in gliomas still remains controversial. In this study, we aimed to evaluate the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bin, Sun, Caixing, Feng, Fang, Ge, Minghua, Xia, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436020/
https://www.ncbi.nlm.nih.gov/pubmed/25967234
http://dx.doi.org/10.1186/s13046-015-0163-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436020/
https://www.ncbi.nlm.nih.gov/pubmed/25967234
http://dx.doi.org/10.1186/s13046-015-0163-4

Ejemplares similares